α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
暂无分享,去创建一个
P. Aebischer | J. Ridet | N. Déglon | P. Aebischer | B. Schneider | C. Lo Bianco | J-L. Ridet | B. L. Schneider | N. Déglon | C. Lo Bianco | Patrick Aebischer | Bernard L. Schneider | C. L. Bianco
[1] L. Mucke,et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.
[2] M. Beal,et al. Experimental models of Parkinson's disease , 2001, Nature Reviews Neuroscience.
[3] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] L. Schmued,et al. Fluoro-Jade: Novel Fluorochromes for Detecting Toxicant-Induced Neuronal Degeneration , 2000, Toxicologic pathology.
[5] J. Ridet,et al. Lentiviral Vectors as a Gene Delivery System in the Mouse Midbrain: Cellular and Behavioral Improvements in a 6-OHDA Model of Parkinson's Disease Using GDNF , 2000, Experimental Neurology.
[6] H. Braak,et al. Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson’s disease are detectable by an advanced silver-staining technique , 1999, Acta Neuropathologica.
[7] Hitoshi Takahashi,et al. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease , 1997, Neuroscience Letters.
[8] Of Flies and Mice , 2000, Science.
[9] P. Lansbury,et al. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. , 2001, Biochemistry.
[10] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[11] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[12] Heidi Phillips,et al. Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.
[13] Pico Caroni,et al. Neuropathology in Mice Expressing Human α-Synuclein , 2000, The Journal of Neuroscience.
[14] M. Spillantini,et al. α‐Synuclein metabolism and aggregation is linked to ubiquitin‐independent degradation by the proteasome , 2001, FEBS letters.
[15] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[16] A. Hottinger,et al. Complete and Long-Term Rescue of Lesioned Adult Motoneurons by Lentiviral-Mediated Expression of Glial Cell Line-Derived Neurotrophic Factor in the Facial Nucleus , 2000, The Journal of Neuroscience.
[17] Akihiko Iwai,et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.
[18] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[19] F. Gage,et al. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.
[20] C. Link,et al. Transgenic invertebrate models of age-associated neurodegenerative diseases , 2001, Mechanisms of Ageing and Development.
[21] J. Bloch,et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.
[22] P. Lansbury,et al. Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. , 2000, Biochemistry.
[23] J. Bloch,et al. Lentiviral Gene Transfer to the Nonhuman Primate Brain , 1999, Experimental Neurology.
[24] L Naldini,et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector , 1997, Journal of virology.
[25] C. Marsden,et al. The α‐synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases , 1998 .
[26] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[27] F. Gage,et al. Bcl-xL protects adult septal cholinergic neurons from axotomized cell death. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[28] Y. Arsenijévic,et al. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. , 2000, Human gene therapy.
[29] D. Dickson,et al. Pathology and Biology of the Lewy Body , 1993, Journal of neuropathology and experimental neurology.
[30] Christian Haass,et al. Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant α-Synuclein in Human and Transgenic Mouse Brain , 2000, The Journal of Neuroscience.
[31] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[32] Steven Finkbeiner,et al. Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.
[33] W. Gibb,et al. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.